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Antibiotic prescribing on two medical wards at 
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ABSTRACT: Antibiotics are frequently prescribed drugs and form a significant part of the 
hospital budget. The literature suggests that prescribing is not without problems and may need 
constant review. We have no data relating to our hospital. This study aims to explore some aspects 
of antibiotic use in our setting. Records of all patients prescribed antibiotics on two medical wards 
over a 4 month period were analysed for indication, choice of antibiotic, outcome and cost. There 
were 126 patients: 54% males; 75.4%, >60 years old; 62% were admitted because of infection. Of 
the whole group, 8.7% received antibiotics with no evidence of infection and no indication for 
prophylaxis. There were 118 infections, 64% respiratory, 13.5% urinary and the rest of 
miscellaneous sites; 14% of infections were nosocomial. Microbiological studies were available in 
only 29% of infections. For 6 patients, the antibiotics prescribed were relatively contraindicated 
because of impaired hepatic and renal function. There was one adverse drug reaction. The total 
drug cost was Lm2181.79; i.v. treatment accounted for 93% of this cost and ceftazidime for 60%. 
There is room for improvement in the selection of antibiotics and their route of adminstration. The 
hospital microbiologists and the Antibiotic Policy should be consulted more often. Laboratory 
diagnosis of infection and biochemical patient monitoring are inadequate. Restricting i.v. 
treatment could reduce cost very substantially. 
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Introduction 
Antibiotics are among the most frequently prescribed 
(and misused) drugs. The topic has been extensively 
reviewed'. In a London hospital,2 in 1981, 28% of 
patients received antibiotics and 28% of these were for 
"medical cases"; 70% of prescriptions were for 
infection, the remainder for prophylaxis . In only 50% of 
cases was the prescriber able to specify which organism 
he/she suspected might be the cause of the infection. 
Lower respiratory tract and urinary "infections" 
accounted for 39 and 20% of prescriptions respectively. 
Interestingly , the same investigators found that as many 
as 40% of prescriptions for lower respiratory tract 
"infections" were unjustifiable3. In 1977, a similar 
study in a North American hospital 4, revealed that 
34.2% of all patients received antibiotics (21.4% 
medical), and as many as 64% were either not indicated 
or had the wrong dose or the choice of drug was 
inappropriate; all when measured against the hospital's 
own policy. 
Several cost-containment policies have been attempted 
with variable degrees of success. Formularies with a 
shift towards generic prescribing, prescribing protocols 
and assertive drug-use evaluation processes have all 
been tried in an attempt to improve prescribing and 
reduce costs5-8 . Educational interventions are possibly 
the best method as the prescriber's prerogatives are 
retained while at the same time he/she has attention 
drawn to possible alternatives, with supporting evidence 
provided by the ward pharmacist9. 
The reality of economic constraints coupled with 
spiralling costs inevitably result in tighter prescribing 
policies. Without input from the clinician, tight policies 
are doomed to failure and without some data on what is 
actually happening at ward level, clinical input by 
doctors cannot be objective. Also, clinicians alone have 
not been as successful as a team effort combining 
clinician and ward pharmacist l . 10. 
In our hospital, the cost of antibiotic prescribing has 
been difficult to calculate and there is little data on the 
spectrum of infection, organ systems involved, reasons 
for prescribing and outcome. Overt infection is 
generally easy to suspect and diagnose. On the other 
hand, the isolation of the pathogen can be difficult. 
Problems of sampling technique and timing, 
microbiological methods and previous empirical 
treatment all contribute to the difficulty. In clinical 
practice, it is often necessary to treat empirically and 
given the severity of infection in the hospital setting, the 
intravenous route is commonly used. The reason may 
be either that the patient is too ill to swallow medication, 
or adequate blood levels can be reliably achieved only 
thus, or the drug itself is only available as an 
intravenous preparation. Notwithstanding these 
problems, it was our impression that antibiotics were not 
always prescribed for good reason, neither was the 
intravenous route al ways justified. Therefore, anything 
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which could be done to shift from a predominantly 
parenteral to an oral route would have obvious 
advantages to patients, healthcare staff and hospital 
managers trying to contain costs 11. We wanted to 
confirm and quantify some of these issues in order to be 
better placed at offering guidelines or at altering 
practice. At the same time, we wished to explore the 
areas of potential and actual adverse drug reactions and 
the financial implications of our antibiotic prescribing. 
The aims of this study therefore, were to determine 
which antibiotics were prescribed, the route of 
administration, the degree and relevance of clinical 
monitoring and the costs of the antibiotic therapy 
actually incurred with the proportion attributable to 
intravenous therapy. As a result, areas might be 
identified where improvement in prescribing and in cost 
containment could be achieved. 
Patients & Methods 
All patients, admitted to two medical wards over a four 
month period (October 1991-February 1992), were 
screened by the ward pham1acists. Prescriptions for 
antibiotics were identified and subsequently monitored 
for actual delivery of the drug to the patient, together 
with its route of administration and any adverse 
reaction. The medical records were analysed for patient 
characteristics, the admitting illness and any other 
conditions, final diagnosis, complete drug history, 
treatment duration and mode of delivery, and laboratory 
investigations. 
Cost of each antibiotic was calculated from unit cost to 
the hospital multiplied by the number of doses given, 
according to route of administration, in each patient. 
Medical and nursing time, cost of infusion sets and other 
ancillary items were not taken into account. 
Results 
There were 126 patients who received antibiotics; 54% 
were males and 75.4% were over 60 years of age. 
Infection was the reason for admission in 62%. In the 
remainder, antibiotics were either prescribed for 
infection which developed after admission or as 
prophylaxis. However, 8.7% of patients received 
antibiotics without having any evidence for infection nor 
an indication for prophylaxis. 
A total of 118 infections were identified, 64% 
respiratory (Table 1), 13.5% urinary and the rest of 
miscellaneous sites (Table 2). Of the total, 14% were 
considered to be nosocomial. Of the 126 patients, 
42.9% had an infection as well as another illness on 
admission. Multiple infections occurred in the same 
Table 1 - Classification of 76 respiratory infections 
pneumonia 12 
bronchopneumonia 12 
aspiration pneumonia 3 
hypostatic pneumonia 6 
bronchitis 16 
infective exacerbation of COPD 9 
asthma with '"infection'" S 
doubtful & unclassifiable 13 
Table 2 - The spectrum of 118 infections in 105 patients 
site of infection community nosocomial microbiology 
acquired available 
respiratory 73 3 13 
urinary S 11 10 
gastrointestinal S 0 3 
wound 3 3 
joint 1 0 
infectious disease 6 0 4 
patient in 10% of cases. The diagnosis of infection was 
supported by positive microbiological tests in 34 
instances (28.8%); in 4 of these by serology. 
Minor abnormalities of plasma biochemistry were 
common. In 6 patients, (5%), they were considered to 
be severe enough by the clinical team to make a relevant 
entry in the case notes and/or to investigate further. In 
spite of this either no apparent cautionary note was 
found even though the choice of antibiotic was relatively 
contraindicated, or no follow-up biochemistry was 
undertaken. There was renal impairment in three 
patients who received full doses of ceftazidime, 
cefuroxime and cephalexin. Two patients had hepatic 
dysfunction and received metronidazole and 
erythromycin. One patient, who had both renal and 
hepatic disease, received gentamicin and metronidazole. 
There was only one adverse drug reaction : a rash due 
to co-trimoxazole. We did not consider inflamed 
venous access sites as adverse reactions. These were, 
however, common and often could be attributed to the 
antibiotic especially where either no other i.v. drugs 
were in use, or where the antibiotic is notorious for 
causing venous inflammation, for example 
erythromycin. 
The antibiotics which were prescribed during the 
period of this study are listed in Table 3, together with 
their unit cost. The total cost of antibiotics for treating 
118 infections in 126 patients amounted to Lm218 1.79; 
with 69.8% of this being due to i.v . erythromycin, 
Table 3 - Unit cost (Lml of each antibiotic used 
l.v. oral 

antibiotic cost dose cost dose 

ampicillin 0.08 SOOmg 0.01 2S0mg 
cloxacillin O.SI SOOmg 0.04 SOOmg 
co-amoxiclav 1.26 1.2g 0.16 37Smg 
cefuroxime 0.70 7S0mg 0.46 2S0mg 
ceftazidime 4.44 19 
ceftriaxone 13.74 2g 
cephalexin 0.03 2S0mg 
ciprof1oxacin S. IO 100mg 0.43 2S0mg 
co-trimoxazole 0.69 320mg 0.10 480mg 
erythromycin U8 300mg 0.01 2S0mg 
f1ucloxacillin 0.35 2S0mg 0.03 2S0mg 
gentamicin 0.11 80mg 
metronidazole O.4S 2.Sg 0.01 2S0mg 
nalidixic acid 0 .03 SOOmg 
neomycin 0.07 SOOmg 
netilmicin U8 ISOmg 
tetracycline 0.90 2S0mg 0.01 250mg 
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ceftazidime and cefuroxim~ (Table 4). There were 210 
prescriptions indicating that several patients received 
combined therapy. 
Table 4 - Total cost (Lm) of each antibiotic (n =patients) 
and the percentage of total cost of Lv. therapy 
I.V. oral cost 
antibiotic n cost n cost cost iv % 
ampicillin 12 10.84 16 6.37 17.21 63 
cloxacillin 10 105.02 4 13.59 118.61 89 
co-amoxiclav 12 194.25 23 49.33 243.58 80 
cefuroxime 32 326.19 3.51 329.70 99 
ceftazidime 8 860.31 860.31 100 
ceftriaxone 7.60 7.60 100 
cephalexin 7 8.58 8.58 0 
ciprofloxacin 122.40 4 43.14 165.54 74 
co-trimoxazole 7 0.72 0.72 0 
erythromycin 9 315.56 23 8.35 323.91 97 
flucloxacillin 3 28.05 3 2.58 30.63 93 
gentamicin 14 21.56 21.56 100 
metronidazole 4 28.92 3 1.27 30.19 96 
nalidixic acid 3 1.82 2.40 0 
neomycin 1.82 1.82 100 
netilmicin 15.84 15.84 100 
tetracycline 8 3.59 3.59 0 
Discussion 
The most common organ systems with infections, in 
patients admitted to the two medical wards studied, were 
respiratory and urinary. It was obvious from the case 
notes that the majority were not immediately life­
threatening. Many were secondary, such as 
exacerbations in COPD, or in patients with urinary 
catheters. 
Respiratory infections dominated (Table I). Three 
cases were considered to be nosocomial and therefore 
could have justified second-line antibiotic choices. All 
the rest (about 70 cases), with rare exception, would 
have been effectively treated with ampicillin and 
erythromycin, alone or in combination, as these were 
community acquired infections. Yet, there were only 28 
and 32 prescriptions for ampicillin and erythromycin 
respectively (some prescriptions for ampicillin were for 
urinary tract infection). This suggests that second-line 
drugs were used in at least half the cases. Since 
microbiology played a minimal role in antibiotic 
selection. clinical criteria must have been used, criteria 
which. evidently. do not correspond with currently 
recommended practice l2 . It would require further study 
to address this issue, to detemline whether or not in fact, 
such prescribing was justified, and whether or not the 
present antibiotic policy is up-to-date. 
Table 4, illustrates the frequency of intravenous 
antibiotic use: 108 out of 210 prescriptions. Therefore, 
even using the same preparation, but reducing the 
number of days on i.v. therapy, could have a significant 
impact on cost. Further benefits would be an increased 
convenience to staff and patients, and a reduction in 
morbidity. 
Prescription of antibiotics without any indication 
whatsoever is of some concern. In a study based in a 
UK teaching hospital,8 less than 2% of their 
prescnptlOns were found to have no indication 
whatsoever as compared with our 8.7%. Furthermore, 
in 10.3% of cases, antibiotics were chosen which were 
relatively contraindicated by the abnormal biochemical 
tests present. Fortunately there were no serious 
consequences to patients. Surprisingly, there was only 
one adverse drug reaction in this study. 
Substantial expense was incurred when treating the 
few patients with life threatening infection. The use of 
high cost drugs, sometimes in combination, is often 
mandatory in such clinical circumstances. 
For common infections, particularly of the respiratory 
tract, it would require more rapid microbiological 
techniques to be developed and/or implemented; and 
even then, the organism would have to be sensitive to 
the first line drugs, in order to permit effective rationing 
of prescriptions. 
In conclusion, some recommendations are offered 
which may help improve prescribing policy and contain 
costs: 
• First line antibiotics (as recommended in the hospital 
antibiotic policy) must be kept up to date by regular 
consultation between microbiologist, pharnlacist and 
relevant specialist clinician. 
• Respiratory and urinary tract infections are the 
commonest infections on medical wards and cheap, 
effective, oral preparations are available but apparently 
under-utilised. 
• Clinicians must seriously consider giving precedence 
to oral therapy but, if the i.v route is chosen. this should 
be changed as early as possible. 
• Better use should be made of microbiologists' 
expertise. 
• Ward pharmacy-based monitoring services targeted 
towards specific antibiotics should be developed. 
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Have you ever thought of sharing xour time 
with a disabled child while its family 
takes a break? 
Now, Family link makes it possible 
to do so in your own home, and doing 
the things you and your family enjoyl call 
Family Link offers you a worthwhile link-une 
caring experience with full, 450104 
NOWprofessional supjpt)rt. 
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